Clinical Trials
14 trialsNCT04723810 2026-03-09
TumorGlow Intraoperative Molecular Imaging (IMI)
University of Pennsylvania
Phase 1/2 Recruiting
NCT03953144 2026-02-02
Synapse 3D With Intravascular Indocyanine Green
St. Joseph's Healthcare Hamilton
Phase 1/2 Recruiting
NCT05346380 2025-11-26
Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download
Massachusetts General Hospital
Phase 1/2 Completed
NCT07108855 2025-08-07
BRIGHT
University Medical Center Groningen
Phase 1/2 Recruiting
NCT00540982 2025-07-02
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
City of Hope Medical Center
Phase 1/2 Completed
NCT06647901 2024-10-18
Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
Peking University People's Hospital
Phase 1/2 Recruiting
NCT05092750 2023-09-28
Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT03745690 2022-03-17
Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer
Jonsson Comprehensive Cancer Center
Phase 1/2 Withdrawn
NCT02710240 2021-10-27
Indocyanine Green for Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT03204994 2019-08-13
Fluorescence Targeted Pelvic Lymph Node Mapping
Oxford University Hospitals NHS Trust
Phase 1/2 Terminated
NCT02946021 2019-04-09
Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema
Tactile Medical
Phase 1/2 Completed
NCT03292757 2018-11-19
FLOTOR
Oxford University Hospitals NHS Trust
Phase 1/2 Completed
NCT03097627 2017-12-12
Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions
Brigham and Women's Hospital
Phase 1/2 Completed
NCT01993576 2014-10-15
EC2075
Jules Bordet Institute
Phase 1/2 Completed